Goods and Services Information
|
Description:
|
(1) - Diagnostics for clinical and scientific research purposes; diagnostic tools, diagnostic preparations, biologics and therapeutics for clinical and scientific research purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic tests used for providing clinical scientific laboratory services according to the Clinical Laboratory Improvement Amendments (CLIA) program, namely, for the detection of diseases, disorders and conditions
(2) - Diagnostics, biologics and therapeutics for medical use, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic kits for medical use, namely, the detection of diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic tests used for providing medical testing services according to the Clinical Laboratory Improvement Amendments (CLIA) program, namely, for the detection of diseases, disorders and conditions
(3) - Promoting technical and scientific investigation, research and experimentation in the field of genomics; promoting technical and scientific investigation, research and experimentation in the field of patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions
(4) - Financial asset and investment management services; financial services, namely, private equity investments and funding in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; investment services, namely, investing in technologies focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; financial services, namely, business fundraising for others; fundraising to support scientific and medical research and procedures; capital investment services
(5) - Biological and pharmaceutical research and development; medical and scientific research; scientific and medical research and consulting in the field of genomics; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions; research, design, development and testing of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of diseases, disorders and conditions; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; compilation of biological and statistical data for research purposes in the fields of medical and scientific research; providing clinical scientific laboratory services for others according to the Clinical Laboratory Improvement Amendments (CLIA) program; CLIA-based medical testing for diagnostic purposes; providing nucleic acid sequencing and analysis services under CLIA certification standards; providing diagnostic services under CLIA certification standards, namely, collecting patient samples, processing and analyzing patient samples, and delivering results of the processing and analysis, all carried out in a CLIA-certified laboratory
(6) - Licensing of intellectual property rights
|